Accuracy of SPD Persona LH Assay When Compared to Ultrasound Observed Ovulation and Other Indices of Ovulation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 51
- 试验地点
- 1
- 主要终点
- Ultrasound
研究概览
简要总结
This study will examine the performance of the Persona assays in identifying the time when risk of pregnancy is highest by comparing results to ultrasound observed ovulation and other indices of ovulation.
详细描述
Persona is a CE marked, natural method of contraception that works by monitoring hormone changes in a woman's urine to identify the days of her menstrual cycle when she is likely to become pregnant following unprotected intercourse. Persona consists of test sticks that measure luteinising hormone (LH) and estrone-3-glucuronide (E3G), which are read by a handheld monitor. This hormonal data is converted using a proprietary algorithm, into simple-to-understand information on the user's contraceptive status; a "red light" where she needs to abstain from intercourse to avoid pregnancy, or a "green light" where unprotected intercourse is unlikely to lead to pregnancy. A prospective 13 cycle reliability study has found Persona to be 94% effective.
This study will examine the relationship between the information provided by the Persona assays and ultrasound observed ovulation, along with other indicators of when a woman is fertile (basal body temperature (BBT) measurement and cervical secretion observations).
This is a single centre clinical study which will be conducted at the green-ivf clinic in Grevenbroich, Germany. The primary objective will be to assess the difference between the timing of the LH surge detected by Persona and observed ovulation by reference to transvaginal ultrasound examination.
In addition, comparison of Persona determined levels of LH and E3G will be made to urine and serum levels of these and other reproductive hormones. Comparison will also be made to BBT and cervical secretion observations which are indirect measurements of the fertile phase.
In order to achieve these objectives, a minimum of 40 female volunteers will be recruited by the study site either out of the patient pool coming for routine gynaecological examination or from the general population via newspaper advertisement.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 40 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Aged 18 - 40 years
- •Menstrual cycle length between 23 and 35 days
- •Had two natural cycles prior to study participation
- •Using non-hormonal contraception to avoid pregnancy OR abstaining from intercourse for the last three months and the present cycle
- •N.B: Non hormonal contraception includes barrier methods such as male and female condoms, diaphragms or caps, non-hormonal intra-uterine devices such as coils, male and female sterilisation or natural family planning
排除标准
- •Unwilling to provide written informed consent to participate in the study or comply with study procedures
- •Breastfeeding
- •Has menopausal symptoms such as night sweats or hot flushes
- •Using any hormonal treatments e.g. hormonal contraception, fertility treatments and hormone replacement therapy (except thyroxin)
- •Taking antibiotics (based on decision by principle investigator)
- •Has a diagnosis of polycystic ovarian syndrome (PCOS)
- •Has impaired liver or kidney function
- •Intending to use PERSONA as a contraceptive during the study period
- •Contraindications to frequent blood sampling e.g. anaemia, hypotonia and blood clotting diseases
- •Contraindications to frequent ultrasound examinations e.g. morbid obesity and recent abdominal surgery
结局指标
主要结局
Ultrasound
时间窗: Participants will be followed for one menstrual cycle, anticipated average of four weeks.
Accuracy of the LH urine assay contained within PERSONA at predicting ovulation, by comparing the day of the LH surge with ultrasound observed ovulation
次要结局
- Quantitative determination of urinary and serum levels of LH and E3G(Participants will be followed one menstrual cycle, an anticipated four weeks)
- Volunteer recorded BBT and cervical secretion observations.(Participants will be followed for one menstrual cycle, an anticipated four weeks)
